Cargando…
The effectiveness of Paxlovid treatment in long-term care facilities in South Korea during the outbreak of the Omicron variant of SARS-CoV-2
OBJECTIVES: On November 5, 2021, Pfizer Inc. announced Paxlovid (nirmatrelvir+ritonavir) as a treatment method that could reduce the risk of hospitalization or death for patients with confirmed coronavirus disease 2019 (COVID-19). METHODS: From February 6, 2022 to April 2, 2022, the incidence of COV...
Autores principales: | Park, Hanul, Park, Young Joon, Lee, Hye Young, Yu, Mi, Song, Yeong-Jun, Lee, Sang Eun, Lee, Ji-Joo, Lee, Eun-Sol, Kim, Yeonjung |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Korea Disease Control and Prevention Agency
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10211435/ https://www.ncbi.nlm.nih.gov/pubmed/36617550 http://dx.doi.org/10.24171/j.phrp.2022.0262 |
Ejemplares similares
-
Early countermeasures to COVID-19 at long-term care facilities in Gwangju Metropolitan City, Republic of Korea
por: Kim, Hye-Jin, et al.
Publicado: (2023) -
Community Transmission of SARS-CoV-2 Omicron Variant, South Korea, 2021
por: Kim, Eun-Young, et al.
Publicado: (2022) -
An Outbreak of Measles in a University in Korea, 2014
por: Choe, Young June, et al.
Publicado: (2017) -
Importation and Transmission of SARS-CoV-2 B.1.1.529 (Omicron) Variant of Concern in Korea, November 2021
por: Lee, Ji Joo, et al.
Publicado: (2021) -
mRNA vaccine effectiveness against SARS-CoV-2 B.1.617.2 (Delta) and B.1.1.529 (Omicron) variant transmission from home care cases to household contacts in South Korea
por: Park, Hanul, et al.
Publicado: (2022)